Dr. Lal PathLabs Ltd - 539524 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report for the Financial Year ended March 31, 202326-04-2023
26-04-2023
Dr. Lal PathLabs Ltd - 539524 - Compliance Under Regulation 40(10) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
With reference to the captioned subject, please find the enclosed certificate for the financial year ended March 31, 2023.14-04-2023
Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
We wish to inform you that, the Board of Directors have on April 12, 2023 approved allotment of 16,000 Equity Shares under the ESOP 2010 Plan of the Company.12-04-2023
Dr. Lal PathLabs Ltd - 539524 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please find enclosed herewith a copy of the Certificate received from Link lntime India Private Limited, the RTA (Registrars & Share Transfer Agent) of the Company viz. Dr. Lal PathLabs Limited, confirming the compliance under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended March 31, 2023.07-04-2023
Dr. Lal PathLabs Ltd - 539524 - Compliance Under Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Year Ended March 31, 2023
With reference to the captioned subject, please find the enclosed certificate for the year ended March 31, 2023.07-04-2023
Dr. Lal PathLabs Ltd - 539524 - Closure of Trading Window
We wish to inform you that as per the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 2015 and Company''s code for Prevention of Insider Trading, the Trading Window for dealing in Securities of the Company shall be closed from April 01, 2023 and would be re-opened after 48 hours from the date of announcement/ declaration of Audited Financial Results for the Quarter and Financial Year ending March 31, 2023. We request you to kindly take the same on record.31-03-2023
Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Please find attached the details of the proposed schedule of Analyst/Institutional Investor meeting(s).30-03-2023
Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Please find attached the details of the proposed schedule of Analyst/Institutional Investor meeting(s).29-03-2023
Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Please find attached the details of the proposed schedule of Analyst/Institutional Investor meeting(s).27-03-2023
Dr. Lal PathLabs Ltd - 539524 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Please find attached the details of the proposed schedule of Analyst/Institutional Investor meeting(s).23-03-2023